Medtronic Plc (MDT) is overvalued and Stryker Corp (SYK) is overvalued.
Both trade above our estimate of their intrinsic value. MDT is the closer of the two: -25%, against -35% for SYK.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.8% (average of 3 methods) values the shares at $72.41; the price of $90.77 is 25% above that value, and 80% of that value comes from beyond year five.
Leak Score 27/100 on 3 of 12 signals
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $204.41; the price of $275.09 is 35% above that value, and 77% of that value comes from beyond year five.
Leak Score 65/100 on 10 of 12 signals
| Metric | MDT | SYK |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $90.77 | $275.09 |
| Intrinsic value | $72.41 | $204.41 |
| Margin of safety | -25% | -35% |
| Leak Score | 27/100 (3/12) | 65/100 (10/12) |
| Market cap | $116.1B | $105.5B |
| Revenue growth, 5 years | 3.8% | 11.8% |
| Operating margin | 19.9% | 24.3% |
| Net margin | 13.9% | 14.4% |
| Return on equity | 10.7% | 16.5% |
| Debt to equity | 0.56 | 0.64 |
| P/E | 22.4x | 28.5x |
| Forward P/E | 14.2x | 16.4x |
| P/B | 2.3x | 4.4x |
| Dividend yield | 3.1% | 1.3% |